Corpus Intelligence IC Memo — MERCY HOSPITAL JOPLIN 2026-04-26 03:43 UTC
IC Memo — MERCY HOSPITAL JOPLIN
Investment Committee Memorandum | MO | 242 beds | Grade C | EBITDA uplift $19.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

MERCY HOSPITAL JOPLIN

CCN 260001 | JASPER, MO | 242 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

MERCY HOSPITAL JOPLIN is a 242-bed suburban community hospital in JASPER, MO with $269.3M in net patient revenue and a 5.3% operating margin. The hospital serves a payer mix of 23.3% Medicare, 12.5% Medicaid, and 64.2% commercial.

Thesis: Platform Growth. Our ML models identify $19.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.3% to 12.7% (+736bps).

Net Revenue HCRIS$269.3M
Current EBITDA COMPUTED$14.3M
Operating Margin COMPUTED5.3%
Occupancy HCRIS63.0%
Revenue / Bed COMPUTED$1.1M
Net-to-Gross HCRIS23.0%
Distress Probability ML46.9%

2. Market Context & Competitive Position

138
MO Hospitals
-6.2%
State Median Margin
34
Comparable Hospitals

MO has 138 Medicare-certified hospitals with a median operating margin of -6.2%. The target's margin of 5.3% places it above the state median. Among 34 size-comparable peers (121-484 beds), the median margin is -3.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (121-484), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
MERCY HOSPITAL JOPLIN (Target)MO242$269.3M5.3%
CHILDRENS MERCY HOSPITALMO328$1.44B30.5%
ST. LOUIS CHILDRENS HOSPITALMO445$886.1M6.4%
SAINT LUKES HOSPITAL OF KANSASMO466$883.5M-12.4%
SSM SAINT LOUIS UNIVERSITY HOSMO317$772.2M-6.4%
MISSOURI BAPTIST MEDICAL CENTEMO402$716.0M2.5%
HEARTLAND REGIONAL MEDICAL CENMO352$676.9M-6.2%
NORTH KANSAS CITY HOSPITALMO383$601.5M7.7%
FREEMAN OAK HILL HEALTH SYSTEMMO363$587.5M3.0%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $19.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$5.7M+210bp18mo
Cost to Collect4.5%2.5%$5.4M+200bp12mo
Denial Rate Reduction12.0%6.5%$5.3M+198bp12mo
A/R Days Reduction5200.0%3800.0%$3.3M+122bp9mo
Clean Claim Rate88.0%96.0%$172K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$5.7M
Cost to Collect
$5.4M
Denial Rate Reduction
$5.3M
A/R Days Reduction
$3.3M
Clean Claim Rate
$172K
Total EBITDA Uplift$19.8M
Current EBITDA$14.3M
+ RCM Uplift+$19.8M
Pro Forma EBITDA$34.1M
Current Margin5.3%
Pro Forma Margin12.7%
WC Released (1x)$10.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$22.0M$292.6M13.29x67.8%
Base (11x exit)10.0x11.0x$22.0M$329.0M14.94x71.8%
Bull Case9.0x11.0x$19.8M$401.6M20.26x82.5%
Bull (12x exit)9.0x12.0x$19.8M$443.9M22.40x86.2%
Bear Case11.0x10.0x$24.2M$186.4M7.69x50.4%
Bear (11x exit)11.0x11.0x$24.2M$212.9M8.79x54.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 121-484 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-12.6% / P50=-3.1% / P75=5.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.